Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
See more

Webinars

See More

Food and Drugs Law

Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
See more

Healthcare

Article
La Reestructuración Financiera: Una Herramienta para el Éxito en la Preservación de Empleos y la Calidad de Servicios de Salud
Puerto Rico's hospital industry faces unprecedented financial pressures from Medicaid cuts, payment delays, and operational challenges. Strategic financial restructuring under Chapter 11 bankruptcy offers a proven path to preserve jobs, maintain patient care, and position hospitals for sustainable growth rather than accepting gradual decline.
Puerto Rico Insolvency
PB
Porzio, Bromberg & Newman
Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
See more